RLAY
Relay Therapeutics Inc
$6.21
Earnings Summary
Revenue | $-0Mn |
Net Profits | $-83.5Mn |
Net Profit Margins | 8349500% |
Highlights
Relay Therapeutics Inc’s revenue fell -100.4% since last year same period to $-0Mn in the Q4 2023. On a quarterly growth basis, Relay Therapeutics Inc has generated -100% fall in its revenue since last 3-months.
Relay Therapeutics Inc’s net profit fell -92.76% since last year same period to $-83.5Mn in the Q4 2023. On a quarterly growth basis, Relay Therapeutics Inc has generated -27.02% fall in its net profits since last 3-months.
Relay Therapeutics Inc’s net profit margin jumped 48868.87% since last year same period to 8349500% in the Q4 2023. On a quarterly growth basis, Relay Therapeutics Inc has generated 3201245.51% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Relay Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Highlights
Relay Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a 2.74% jump from last quarter’s estimates.
Relay Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.71.
Key Ratios
Key ratios of the Relay Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.67 |
Highlights
Relay Therapeutics Inc’s earning per share (EPS) fell -19.64% since last year same period to -0.67 in the Q4 2023. This indicates that the Relay Therapeutics Inc has generated -19.64% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-22 | -0.73 | -0.67 | 8.22% |
2023-05-04 | -0.69 | -0.78 | -13.04% |
2023-08-08 | -0.82 | -0.81 | 1.22% |
2023-11-02 | -0.83 | -0.54 | 34.94% |
₹0 US Stocks a/c Opening Fee